CAR-T-cell neurotoxicity: hope is on the horizon

Affiliations

Free article

Comment

Omar Ahmed. Blood. 2019.

Free article

. 2019 May 16;133(20):2114-2116.

doi: 10.1182/blood-2019-03-900985.

No abstract available

Conflict of interest statement

Conflict-of-interest disclosure: O.A. is employed by Humanigen.

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.
Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Gonzalez Castro LN, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J. Karschnia P, et al. Blood. 2019 May 16;133(20):2212-2221. doi: 10.1182/blood-2018-12-893396. Epub 2019 Feb 26. Blood. 2019. PMID: 30808634